Clinical trial
Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal…
NCT00367718 · Johns Hopkins University, Other · Withdrawn
Key facts
| NCT number | NCT00367718 |
|---|---|
| Title | Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma |
| Official title | A Phase II Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Janssen-Cilag Ltd. Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nasopharyngeal Carcinoma |
| Intervention type | Drug |
| Interventions | Velcade |
| Enrollment | 0 |
| First posted | Aug 23, 2006 |
| Last update posted | May 18, 2020 |
| Countries | China, Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: